Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-04-11

AUTHORS

Ophélie Dos Santos-Schaller, Sandrine Boisset, Arnaud Seigneurin, Olivier Epaulard

ABSTRACT

GoalsTo determine whether patients with a pre-existing PPI treatment had a higher risk of poor evolution (recurrence or death) when diagnosed with a toxicogenic Clostridium difficile digestive infection.BackgroundPrevious studies identified pump proton inhibitor (PPI) prescription as a risk factor for C. difficile infection. The influence of PPI on the outcome of C. difficile infection is controversial.StudyThis was a retrospective monocentric cohort study. All cases of patients in our center with a symptomatic infection by a toxicogenic C. difficile strain during the years 2012 and 2013 were retrospectively analyzed. The primary endpoint was the occurrence of a recurrence or C. difficile infection -related death within 2 months after diagnosis.Results373 patients were included in this study (198 men and 175 women), with a mean age of 70.1 ± 18.6 years (2–100 years). Fourteen (3.7 %) patients died secondarily to C. difficile infection (median survival time 5 days), and 88 (23.6 %) experienced recurrence (after a median delay of 30 days). One hundred and ninety eight (53.1 %) patients were already receiving PPI at the time of the C. difficile infection (including 156 patients with a prescription >1 month). When analyzing separately men and women, male patients were more likely to experience recurrence or death in case of pre-existing PPI prescription [HR = 2.32 (1.26–4.27)]; this was not observed in female patients [HR = 0.62 (0.31–1.22)].ConclusionsPre-existing PPI therapy may increase the risk of recurrence or death in male patients with a toxicogenic C. difficile infection. PPI risk–benefit ratio should be carefully assessed. More... »

PAGES

430

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40064-016-2058-z

DOI

http://dx.doi.org/10.1186/s40064-016-2058-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027096342

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27104118


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Faculty of Medicine, Grenoble Institute of Clinical, Biological and Epidemiological Infectiology, Grenoble, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Infectious Disease Unit, Grenoble University Hospital, Grenoble, France", 
            "Faculty of Medicine, Grenoble Institute of Clinical, Biological and Epidemiological Infectiology, Grenoble, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dos Santos-Schaller", 
        "givenName": "Oph\u00e9lie", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Bacteriology, Grenoble University Hospital, Grenoble, France", 
          "id": "http://www.grid.ac/institutes/grid.410529.b", 
          "name": [
            "Faculty of Medicine, Grenoble Institute of Clinical, Biological and Epidemiological Infectiology, Grenoble, France", 
            "Laboratory of Bacteriology, Grenoble University Hospital, Grenoble, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Boisset", 
        "givenName": "Sandrine", 
        "id": "sg:person.01074116263.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074116263.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Computational and Mathematical Biology, TIMC-IMAG UMR 5525, Grenoble, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Quality Science and Medical Evaluation Unit, Grenoble University Hospital, Grenoble, France", 
            "Computational and Mathematical Biology, TIMC-IMAG UMR 5525, Grenoble, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seigneurin", 
        "givenName": "Arnaud", 
        "id": "sg:person.01141437377.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141437377.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service des Maladies Infectieuses, CHU de Grenoble, CS10217, 38043, Grenoble Cedex 09, France", 
          "id": "http://www.grid.ac/institutes/grid.410529.b", 
          "name": [
            "Infectious Disease Unit, Grenoble University Hospital, Grenoble, France", 
            "Faculty of Medicine, Grenoble Institute of Clinical, Biological and Epidemiological Infectiology, Grenoble, France", 
            "Service des Maladies Infectieuses, CHU de Grenoble, CS10217, 38043, Grenoble Cedex 09, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Epaulard", 
        "givenName": "Olivier", 
        "id": "sg:person.0576007606.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576007606.12"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ajg.2012.108", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046477150", 
          "https://doi.org/10.1038/ajg.2012.108"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2012.179", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009988618", 
          "https://doi.org/10.1038/ajg.2012.179"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10096-011-1477-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022764933", 
          "https://doi.org/10.1007/s10096-011-1477-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ajg.2013.333", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002641223", 
          "https://doi.org/10.1038/ajg.2013.333"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-04-11", 
    "datePublishedReg": "2016-04-11", 
    "description": "GoalsTo determine whether patients with a pre-existing PPI treatment had a higher risk of poor evolution (recurrence or death) when diagnosed with a toxicogenic Clostridium difficile digestive infection.BackgroundPrevious studies identified pump proton inhibitor (PPI) prescription as a risk factor for C. difficile infection. The influence of PPI on the outcome of C. difficile infection is controversial.StudyThis was a retrospective monocentric cohort study. All cases of patients in our center with a symptomatic infection by a toxicogenic C. difficile strain during the years 2012 and 2013 were retrospectively analyzed. The primary endpoint was the occurrence of a recurrence or C. difficile infection -related death within 2\u00a0months after diagnosis.Results373 patients were included in this study (198 men and 175 women), with a mean age of 70.1\u00a0\u00b1\u00a018.6\u00a0years (2\u2013100\u00a0years). Fourteen (3.7\u00a0%) patients died secondarily to C. difficile infection (median survival time 5\u00a0days), and 88 (23.6\u00a0%) experienced recurrence (after a median delay of 30\u00a0days). One hundred and ninety eight (53.1\u00a0%) patients were already receiving PPI at the time of the C. difficile infection (including 156 patients with a prescription >1\u00a0month). When analyzing separately men and women, male patients were more likely to experience recurrence or death in case of pre-existing PPI prescription [HR\u00a0=\u00a02.32 (1.26\u20134.27)]; this was not observed in female patients [HR\u00a0=\u00a00.62 (0.31\u20131.22)].ConclusionsPre-existing PPI therapy may increase the risk of recurrence or death in male patients with a toxicogenic C. difficile infection. PPI risk\u2013benefit ratio should be carefully assessed.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s40064-016-2058-z", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1047790", 
        "issn": [
          "2193-1801"
        ], 
        "name": "SpringerPlus", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "5"
      }
    ], 
    "keywords": [
      "difficile infection", 
      "male patients", 
      "proton pump inhibitor therapy", 
      "retrospective monocentric cohort study", 
      "monocentric cohort study", 
      "infection-related deaths", 
      "risk of recurrence", 
      "C. difficile infection", 
      "risk-benefit ratio", 
      "Clostridium difficile infection", 
      "cases of patients", 
      "PPI therapy", 
      "inhibitor prescription", 
      "primary endpoint", 
      "PPI prescriptions", 
      "PPI treatment", 
      "cohort study", 
      "inhibitor therapy", 
      "symptomatic infection", 
      "female patients", 
      "poor evolution", 
      "mean age", 
      "digestive infections", 
      "risk factors", 
      "BackgroundPrevious studies", 
      "high risk", 
      "patients", 
      "recurrence", 
      "difficile strains", 
      "infection", 
      "death", 
      "therapy", 
      "influence of PPI", 
      "prescription", 
      "risk", 
      "StudyThis", 
      "ConclusionsPre", 
      "diagnosis", 
      "GoalsTo", 
      "PPI", 
      "endpoint", 
      "months", 
      "women", 
      "study", 
      "outcomes", 
      "age", 
      "year 2012", 
      "men", 
      "treatment", 
      "cases", 
      "years", 
      "factors", 
      "center", 
      "occurrence", 
      "strains", 
      "ratio", 
      "time", 
      "influence", 
      "evolution"
    ], 
    "name": "Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy", 
    "pagination": "430", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027096342"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40064-016-2058-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27104118"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40064-016-2058-z", 
      "https://app.dimensions.ai/details/publication/pub.1027096342"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_691.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s40064-016-2058-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40064-016-2058-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40064-016-2058-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40064-016-2058-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40064-016-2058-z'


 

This table displays all metadata directly associated to this object as RDF triples.

166 TRIPLES      21 PREDICATES      88 URIs      76 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40064-016-2058-z schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author N17016fced95343fda358aa3c29d80725
4 schema:citation sg:pub.10.1007/s10096-011-1477-6
5 sg:pub.10.1038/ajg.2012.108
6 sg:pub.10.1038/ajg.2012.179
7 sg:pub.10.1038/ajg.2013.333
8 schema:datePublished 2016-04-11
9 schema:datePublishedReg 2016-04-11
10 schema:description GoalsTo determine whether patients with a pre-existing PPI treatment had a higher risk of poor evolution (recurrence or death) when diagnosed with a toxicogenic Clostridium difficile digestive infection.BackgroundPrevious studies identified pump proton inhibitor (PPI) prescription as a risk factor for C. difficile infection. The influence of PPI on the outcome of C. difficile infection is controversial.StudyThis was a retrospective monocentric cohort study. All cases of patients in our center with a symptomatic infection by a toxicogenic C. difficile strain during the years 2012 and 2013 were retrospectively analyzed. The primary endpoint was the occurrence of a recurrence or C. difficile infection -related death within 2 months after diagnosis.Results373 patients were included in this study (198 men and 175 women), with a mean age of 70.1 ± 18.6 years (2–100 years). Fourteen (3.7 %) patients died secondarily to C. difficile infection (median survival time 5 days), and 88 (23.6 %) experienced recurrence (after a median delay of 30 days). One hundred and ninety eight (53.1 %) patients were already receiving PPI at the time of the C. difficile infection (including 156 patients with a prescription >1 month). When analyzing separately men and women, male patients were more likely to experience recurrence or death in case of pre-existing PPI prescription [HR = 2.32 (1.26–4.27)]; this was not observed in female patients [HR = 0.62 (0.31–1.22)].ConclusionsPre-existing PPI therapy may increase the risk of recurrence or death in male patients with a toxicogenic C. difficile infection. PPI risk–benefit ratio should be carefully assessed.
11 schema:genre article
12 schema:isAccessibleForFree true
13 schema:isPartOf Nabb2fbf32ad542bc98365c67299d1d5d
14 Ne9ec89b9ece445c79a094644bf269b91
15 sg:journal.1047790
16 schema:keywords BackgroundPrevious studies
17 C. difficile infection
18 Clostridium difficile infection
19 ConclusionsPre
20 GoalsTo
21 PPI
22 PPI prescriptions
23 PPI therapy
24 PPI treatment
25 StudyThis
26 age
27 cases
28 cases of patients
29 center
30 cohort study
31 death
32 diagnosis
33 difficile infection
34 difficile strains
35 digestive infections
36 endpoint
37 evolution
38 factors
39 female patients
40 high risk
41 infection
42 infection-related deaths
43 influence
44 influence of PPI
45 inhibitor prescription
46 inhibitor therapy
47 male patients
48 mean age
49 men
50 monocentric cohort study
51 months
52 occurrence
53 outcomes
54 patients
55 poor evolution
56 prescription
57 primary endpoint
58 proton pump inhibitor therapy
59 ratio
60 recurrence
61 retrospective monocentric cohort study
62 risk
63 risk factors
64 risk of recurrence
65 risk-benefit ratio
66 strains
67 study
68 symptomatic infection
69 therapy
70 time
71 treatment
72 women
73 year 2012
74 years
75 schema:name Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy
76 schema:pagination 430
77 schema:productId N3a6de88cbeb34e6e9d7a94b8815cca4f
78 N3d2c9191a5ad4ee2bdaba1ea91643754
79 N5a37a0295942496880f9c45f6474f3a8
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027096342
81 https://doi.org/10.1186/s40064-016-2058-z
82 schema:sdDatePublished 2022-10-01T06:41
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher Nf28f9bee47d54b8d9ef19306f7bf7dbe
85 schema:url https://doi.org/10.1186/s40064-016-2058-z
86 sgo:license sg:explorer/license/
87 sgo:sdDataset articles
88 rdf:type schema:ScholarlyArticle
89 N14f9f45db40041d9b30491365c73da43 rdf:first sg:person.01074116263.56
90 rdf:rest N627c67896e7e4b96b7cd3f9266847f84
91 N17016fced95343fda358aa3c29d80725 rdf:first Ncd801ee2403a404cbda86fd22eb04f2f
92 rdf:rest N14f9f45db40041d9b30491365c73da43
93 N3a6de88cbeb34e6e9d7a94b8815cca4f schema:name pubmed_id
94 schema:value 27104118
95 rdf:type schema:PropertyValue
96 N3d2c9191a5ad4ee2bdaba1ea91643754 schema:name dimensions_id
97 schema:value pub.1027096342
98 rdf:type schema:PropertyValue
99 N45042a53c2ba431f8bd7692394f9ac07 rdf:first sg:person.0576007606.12
100 rdf:rest rdf:nil
101 N5a37a0295942496880f9c45f6474f3a8 schema:name doi
102 schema:value 10.1186/s40064-016-2058-z
103 rdf:type schema:PropertyValue
104 N627c67896e7e4b96b7cd3f9266847f84 rdf:first sg:person.01141437377.40
105 rdf:rest N45042a53c2ba431f8bd7692394f9ac07
106 Nabb2fbf32ad542bc98365c67299d1d5d schema:volumeNumber 5
107 rdf:type schema:PublicationVolume
108 Ncd801ee2403a404cbda86fd22eb04f2f schema:affiliation grid-institutes:None
109 schema:familyName Dos Santos-Schaller
110 schema:givenName Ophélie
111 rdf:type schema:Person
112 Ne9ec89b9ece445c79a094644bf269b91 schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 Nf28f9bee47d54b8d9ef19306f7bf7dbe schema:name Springer Nature - SN SciGraph project
115 rdf:type schema:Organization
116 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
117 schema:name Medical and Health Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
120 schema:name Public Health and Health Services
121 rdf:type schema:DefinedTerm
122 sg:journal.1047790 schema:issn 2193-1801
123 schema:name SpringerPlus
124 schema:publisher Springer Nature
125 rdf:type schema:Periodical
126 sg:person.01074116263.56 schema:affiliation grid-institutes:grid.410529.b
127 schema:familyName Boisset
128 schema:givenName Sandrine
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074116263.56
130 rdf:type schema:Person
131 sg:person.01141437377.40 schema:affiliation grid-institutes:None
132 schema:familyName Seigneurin
133 schema:givenName Arnaud
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01141437377.40
135 rdf:type schema:Person
136 sg:person.0576007606.12 schema:affiliation grid-institutes:grid.410529.b
137 schema:familyName Epaulard
138 schema:givenName Olivier
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576007606.12
140 rdf:type schema:Person
141 sg:pub.10.1007/s10096-011-1477-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022764933
142 https://doi.org/10.1007/s10096-011-1477-6
143 rdf:type schema:CreativeWork
144 sg:pub.10.1038/ajg.2012.108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046477150
145 https://doi.org/10.1038/ajg.2012.108
146 rdf:type schema:CreativeWork
147 sg:pub.10.1038/ajg.2012.179 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009988618
148 https://doi.org/10.1038/ajg.2012.179
149 rdf:type schema:CreativeWork
150 sg:pub.10.1038/ajg.2013.333 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002641223
151 https://doi.org/10.1038/ajg.2013.333
152 rdf:type schema:CreativeWork
153 grid-institutes:None schema:alternateName Computational and Mathematical Biology, TIMC-IMAG UMR 5525, Grenoble, France
154 Faculty of Medicine, Grenoble Institute of Clinical, Biological and Epidemiological Infectiology, Grenoble, France
155 schema:name Computational and Mathematical Biology, TIMC-IMAG UMR 5525, Grenoble, France
156 Faculty of Medicine, Grenoble Institute of Clinical, Biological and Epidemiological Infectiology, Grenoble, France
157 Infectious Disease Unit, Grenoble University Hospital, Grenoble, France
158 Quality Science and Medical Evaluation Unit, Grenoble University Hospital, Grenoble, France
159 rdf:type schema:Organization
160 grid-institutes:grid.410529.b schema:alternateName Laboratory of Bacteriology, Grenoble University Hospital, Grenoble, France
161 Service des Maladies Infectieuses, CHU de Grenoble, CS10217, 38043, Grenoble Cedex 09, France
162 schema:name Faculty of Medicine, Grenoble Institute of Clinical, Biological and Epidemiological Infectiology, Grenoble, France
163 Infectious Disease Unit, Grenoble University Hospital, Grenoble, France
164 Laboratory of Bacteriology, Grenoble University Hospital, Grenoble, France
165 Service des Maladies Infectieuses, CHU de Grenoble, CS10217, 38043, Grenoble Cedex 09, France
166 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...